HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
10 sources retrieved Β· Most recent: April 2026 Β· Index updated 15 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
ZMYND10
zinc finger MYND-type containing 10
Chromosome 3 Β· 3p21.31
NCBI Gene: 51364Ensembl: ENSG00000004838.15HGNC: HGNC:19412UniProt: O75800
54PubMed Papers
21Diseases
0Drugs
34Pathogenic Variants
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein bindingouter dynein arm assemblyinner dynein arm assemblymotile cilium assemblyprimary ciliary dyskinesiagenetic disorderneoplasmnasopharyngeal carcinoma
✦AI Summary

ZMYND10 (zinc finger MYND-type containing 10) is a cytoplasmic protein essential for axonemal dynein arm assembly and cilia motility. Primary function: ZMYND10 regulates the cytoplasmic pre-assembly of both inner dynein arms (IDA) and outer dynein arms (ODA) required for proper axoneme structure 1. Mechanism: ZMYND10 acts as a co-chaperone that confers specificity for the FKBP8-HSP90 chaperone complex toward axonemal dynein clients 2. It stabilizes intermediate chain proteins including DNAI1, which subsequently stabilizes other dynein components 3. ZMYND10 interacts with ODA assembly factors such as LRRC6, DYX1C1, and C21ORF59 4. Disease relevance: Biallelic ZMYND10 mutations cause primary ciliary dyskinesia (PCD) characterized by absent or severely reduced dynein arms, complete cilia immotility, hydrocephalus, laterality defects, and male infertility 1. Clinical significance: ZMYND10 mutations account for approximately 16% of PCD cases with combined IDA and ODA defects 1. Disease-causing variants disrupt the FKBP8-HSP90 co-chaperone function, suggesting PCD represents a cell-type specific protein-misfolding disease 2. Beyond ciliary function, ZMYND10 exhibits tumor-suppressive properties in breast cancer through miR145-5p/NEDD9 regulation 5.

Sources cited
1
ZMYND10 mutations cause PCD with IDA and ODA defects, complete cilia immotility, and laterality defects; accounts for 16% of combined IDA/ODA PCD cases
PMID: 23891471
2
ZMYND10 functions as a co-chaperone for FKBP8-HSP90 complex directing it toward axonemal dynein substrates; disease-causing variants disrupt co-chaperone function
PMID: 29916806
3
ZMYND10 stabilizes intermediate chain proteins (DNAI1) in cytoplasmic pre-assembly of dynein arms; interacts with ODA components and assembly factors
PMID: 29601588
4
ZMYND10 interacts with LRRC6 and colocalizes with centriole markers; mutations result in absence of axonemal proteins DNAH5 and DNALI1
PMID: 23891469
5
ZMYND10 exerts tumor-suppressive functions in breast cancer via miR145-5p/NEDD9 axis
PMID: 31801619
Disease Associationsβ“˜21
primary ciliary dyskinesiaOpen Targets
0.78Strong
genetic disorderOpen Targets
0.19Weak
neoplasmOpen Targets
0.08Suggestive
nasopharyngeal carcinomaOpen Targets
0.08Suggestive
breast cancerOpen Targets
0.08Suggestive
placenta praeviaOpen Targets
0.04Suggestive
schizophreniaOpen Targets
0.04Suggestive
ciliopathyOpen Targets
0.04Suggestive
Abnormality of the skeletal systemOpen Targets
0.03Suggestive
ciliary dyskinesia, primary, 48, without situs inversusOpen Targets
0.03Suggestive
primary ciliary dyskinesia 5Open Targets
0.03Suggestive
ciliary dyskinesia, primary, 43Open Targets
0.03Suggestive
infectionOpen Targets
0.02Suggestive
breast neoplasmOpen Targets
0.02Suggestive
childhood supratentorial ependymomaOpen Targets
0.02Suggestive
generalised epilepsyOpen Targets
0.02Suggestive
scoliosisOpen Targets
0.02Suggestive
non-small cell lung carcinomaOpen Targets
0.02Suggestive
influenzaOpen Targets
0.02Suggestive
gliomaOpen Targets
0.02Suggestive
Ciliary dyskinesia, primary, 22UniProt
Pathogenic Variants34
NM_015896.4(ZMYND10):c.47T>G (p.Val16Gly)Pathogenic
Primary ciliary dyskinesia 22|Kartagener syndrome|Primary ciliary dyskinesia|not provided|ZMYND10-related disorder
β˜…β˜…β˜†β˜†2026β†’ Residue 16
NM_015896.4(ZMYND10):c.797T>C (p.Leu266Pro)Pathogenic
Primary ciliary dyskinesia 22|Primary ciliary dyskinesia
β˜…β˜…β˜†β˜†2026β†’ Residue 266
NM_015896.4(ZMYND10):c.183_187del (p.Leu62fs)Pathogenic
Primary ciliary dyskinesia|Primary ciliary dyskinesia 22
β˜…β˜…β˜†β˜†2025β†’ Residue 62
NM_015896.4(ZMYND10):c.510+1G>APathogenic
Primary ciliary dyskinesia|not provided
β˜…β˜…β˜†β˜†2025
NM_015896.4(ZMYND10):c.709C>T (p.Gln237Ter)Pathogenic
Primary ciliary dyskinesia|ZMYND10-related disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 237
NM_015896.4(ZMYND10):c.931C>T (p.Gln311Ter)Pathogenic
Primary ciliary dyskinesia|Primary ciliary dyskinesia 22
β˜…β˜…β˜†β˜†2024β†’ Residue 311
NM_015896.4(ZMYND10):c.490C>T (p.Gln164Ter)Pathogenic
Primary ciliary dyskinesia 22|Primary ciliary dyskinesia
β˜…β˜…β˜†β˜†2022β†’ Residue 164
NM_015896.4(ZMYND10):c.3G>A (p.Met1Ile)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2025β†’ Residue 1
NM_015896.4(ZMYND10):c.1191C>A (p.Cys397Ter)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2025β†’ Residue 397
NM_015896.4(ZMYND10):c.1A>G (p.Met1Val)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2025β†’ Residue 1
NM_015896.4(ZMYND10):c.85T>C (p.Ser29Pro)Pathogenic
Primary ciliary dyskinesia|ZMYND10-related disorder
β˜…β˜†β˜†β˜†2025β†’ Residue 29
NM_015896.4(ZMYND10):c.1096C>T (p.Gln366Ter)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2025β†’ Residue 366
NM_015896.4(ZMYND10):c.383_384del (p.Glu128fs)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2025β†’ Residue 128
NM_015896.4(ZMYND10):c.1121+1G>ALikely pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2024
NM_015896.4(ZMYND10):c.967del (p.Gln323fs)Likely pathogenic
Primary ciliary dyskinesia 22
β˜…β˜†β˜†β˜†2024β†’ Residue 323
NM_015896.4(ZMYND10):c.732G>A (p.Trp244Ter)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2024β†’ Residue 244
NM_015896.4(ZMYND10):c.967C>T (p.Gln323Ter)Pathogenic
Primary ciliary dyskinesia 22|Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2024β†’ Residue 323
NM_015896.4(ZMYND10):c.1046G>A (p.Trp349Ter)Pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2024β†’ Residue 349
NM_015896.4(ZMYND10):c.511-1G>ALikely pathogenic
Primary ciliary dyskinesia
β˜…β˜†β˜†β˜†2024
NM_015896.4(ZMYND10):c.700+2T>CPathogenic
Primary ciliary dyskinesia 22
β˜…β˜†β˜†β˜†2024
View on ClinVar β†—
Related Genes
RSPH9Protein interaction100%RSPH1Protein interaction99%DNAI2Protein interaction96%DNAAF1Protein interaction94%DNAAF2Protein interaction93%CCDC39Protein interaction88%
Tissue Expression6 tissues
Bone Marrow
100%
Lung
61%
Brain
52%
Liver
40%
Ovary
18%
Heart
5%
Gene Interaction Network
Click a node to explore
ZMYND10RSPH9RSPH1DNAI2DNAAF1DNAAF2CCDC39
PROTEIN STRUCTURE
Preparing viewer…
PDB2D8Q Β· NMR
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
1.01LoF Tolerant
pLIβ“˜
0.00Tolerant
Observed/Expected LoF0.80 [0.64–1.01]
RankingsWhere ZMYND10 stands among ~20K protein-coding genes
  • #8,388of 20,598
    Most Researched54
  • #1,704of 5,498
    Most Pathogenic Variants34
  • #9,792of 17,882
    Most Constrained (LOEUF)1.01
Genes detectedZMYND10
Sources retrieved10 papers
Response timeβ€”
πŸ“„ Sources
10β–Ό
1
Mutations in ZMYND10, a gene essential for proper axonemal assembly of inner and outer dynein arms in humans and flies, cause primary ciliary dyskinesia.
PMID: 23891471
Am J Hum Genet Β· 2013
1.00
2
DNA methylation biomarkers for nasopharyngeal carcinoma.
PMID: 32271791
PLoS One Β· 2020
0.90
3
Molecular Insights into Outer Dynein Arm Defects in Primary Ciliary Dyskinesia: Involvement of ZMYND10 and GRP78.
PMID: 40558543
Cells Β· 2025
0.80
4
ZMYND10, an epigenetically regulated tumor suppressor, exerts tumor-suppressive functions via miR145-5p/NEDD9 axis in breast cancer.
PMID: 31801619
Clin Epigenetics Β· 2019
0.70
5
ZMYND10 stabilizes intermediate chain proteins in the cytoplasmic pre-assembly of dynein arms.
PMID: 29601588
PLoS Genet Β· 2018
0.60